financetom
Business
financetom
/
Business
/
Ocular Therapeutix Insider Sold Shares Worth $277,790, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ocular Therapeutix Insider Sold Shares Worth $277,790, According to a Recent SEC Filing
Nov 7, 2025 1:36 PM

04:08 PM EST, 11/07/2025 (MT Newswires) -- Namrata Saroj, Chief Business Officer, on November 05, 2025, sold 25,865 shares in Ocular Therapeutix ( OCUL ) for $277,790. Following the Form 4 filing with the SEC, Saroj has control over a total of 174,135 common shares of the company, with 174,135 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1393434/000110465925108455/xslF345X05/tm2530550-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Buckle Shows Resilient Consumer Spending With Stronger Sales Across Channels
Buckle Shows Resilient Consumer Spending With Stronger Sales Across Channels
Nov 21, 2025
Buckle, Inc. ( BKE ) shares fell Friday after the company reported third-quarter 2025 results. • BKE stock may gain traction. See the full story here. The latest quarterly results showed strong consumer demand but a razor-thin revenue miss. The company reported third-quarter earnings per share of 96 cents, in line with the analyst consensus estimate. Also Read: BJ’s Wholesale Shines As...
Lilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom
Lilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom
Nov 21, 2025
(Reuters) -Eli Lilly ( LLY ) hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market....
Takeda Pharmaceutical's Adzynma Under US FDA Probe Following Death of Pediatric Patient
Takeda Pharmaceutical's Adzynma Under US FDA Probe Following Death of Pediatric Patient
Nov 21, 2025
09:50 AM EST, 11/21/2025 (MT Newswires) -- Takeda Pharmaceutical's ( TAK ) Adzynma is being investigated by the US Food and Drug Administration following the death of a pediatric patient related to the drug, which is intended to treat congenital thrombotic thrombocytopenic purpura, the regulator said Friday. Prior to treatment with Adzynma, this patient had severe allergic reactions to fresh...
Copper giant Codelco signs deal with India's Adani for exploration in Chile
Copper giant Codelco signs deal with India's Adani for exploration in Chile
Nov 21, 2025
SANTIAGO, Nov 21 (Reuters) - Chilean miner Codelco and India's Adani Group have signed an agreement for copper project exploration in Chile, Codelco said in a statement on Friday. The agreement includes the review of three copper projects and sets framework for potential joint development, the Chilean state-run miner said in a statement. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved